Loading data for ICUI — first visit, this takes a few seconds.

ICU Medical, Inc. (ICUI)

NasdaqGS: ICUI · 实时价格 · USD

170.81

-2.14 (-1.24%)

收盘价： Sep 04, 2026, 8:00 PM

提醒

Alert

股价、关键数字和最新消息，都在这一页。

暂无数据

买价	123.49
市值	4.19B
营收（TTM）	2.16B
净利润（TTM）	30.1M
	0.76
	1.19
	140.82
	17.37
市净率（TTM）	1.95
市销率（TTM）	1.94
财报日期	Nov 5, 2026

卖价	219.91
成交量	326,369
20日均量	299,279
开盘价	173.13
前收盘价	172.95
日内区间	170.42 - 176.43
52周区间	112.50 - 192.85
分析师	n/a
目标价	n/a
分红	n/a
除息日	n/a

关于 ICUI

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free conn...

[阅读更多]

行业 Medical Instruments & Supplies

板块 Healthcare

上市日期 Mar 31, 1992

员工人数 13,000

交易所 NasdaqGS

股票代码 ICUI

官网 https://www.icumed.com

公司完整简介

财务表现

2025年，ICU Medical的营收为2.23B，较上一年的2.38B下降-6.33%。净利润为732K，下降-100.62%。

财务报表

财报意外

ICU Medical 已于 Aug 6, 2026 发布季度财报：

营收为 $551.68M 低于预期 $0, ， 0.51% 同比增长.
每股收益为 2.37 超出预期 0.46, ， 12.86% 同比增长.

下次财报发布时间

ICU Medical, Inc. 的下次财报预计于 Nov 5, 2026, 盘中。
分析师预计营收为 ... 升级

股价变动原因

新闻

2周前 · StockStory

Q2 Earnings Highlights: ICU Medical (NASDAQ:ICUI) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

Let’s dig into the relative performance of ICU Medical (NASDAQ:ICUI) and its peers as we unravel the now-completed Q2 medical devices & supplies - cardiology, neurology, vascular earnings season.

3周前 · StockStory

1 Small-Cap Stock with Promising Prospects and 2 We Brush Off

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside ri...

3周前 · StockStory

ICU Medical (ICUI): Buy, Sell, or Hold Post Q2 Earnings?

ICU Medical has had an impressive run over the past six months as its shares have beaten the S&P 500 by 9.3%. The stock now trades at $182.79, marking a 23.3% gain. This was partly due to its solid qu...

3周前 · StockStory

The 5 Most Interesting Analyst Questions From ICU Medical’s Q2 Earnings Call

ICU Medical’s second quarter results were well received by the market, with management highlighting robust performance in the Infusion Systems and Consumables segments as key drivers. CEO Vivek Jain e...

3周前 · StockStory

2 Russell 2000 Stocks to Target This Week and 1 That Underwhelm

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher vol...

第 1 页，共 2 页

ICU Medical, Inc. (ICUI)